Company
Sensydia
Accurate, Non-invasive Hemodynamic Measurement
Also known as Sensydia Corp, Sensydia Corporation
- Status
- Operatingas of 2026-09-18
- Business model
- B2B
- Headquarters
- Valencia, CA, United States
- Customers
- hospitals and clinics
- Legal name
- Sensydia Corporation
- sensydia.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 23 October 2026
About
Sensydia's mission is to advance cardiovascular and critical patient care by overcoming today's limitations in acquiring vital hemodynamic measures. The Sensydia Cardiac Performance System™ (CPS) is designed to deliver accuracy equivalent to gold-standard measures on a single, automated and non-invasive platform.
Funding snapshot
- Total raised
- $17.6MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Undisclosed, $6M2026-10-13
Funding rounds
- Round, 2026
- $6M2026-10-13, Announced
- Round, 2023
- $7.8M2023-05-02, SEC form D sold, 23 investors
- Round, 2020
- $4.1M2020-07-10, SEC form D sold, 25 investors
- Round, 2017
- $3.7M2017-07-20, SEC form D sold, 11 investors
- Round, 2016
- $2M2016-03-29, SEC form D sold, 13 investors
Products
- Hardware
- Sensydia Cardiac Performance System™ (CPS)
Loading relationship preview